Circulating Tumor Cells Patent Landscape and Forecast 2024-2032 - The U.S. Leads with Over 4,000 Patent Filings, Driven by Robust R&D Infrastructure and Substantial Investments in Cancer Diagnostics
November 12, 2024 08:11 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032" has been added to ResearchAndMarkets.com's offering.The circulating tumor...
U.S. Liquid Biopsy Market Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031
June 04, 2024 04:08 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application, End User, Clinical...
Global Liquid Biopsy Market Report 2024: Early Cancer Screening Segment Accounted for the Highest Growth Rate in the Liquid Biopsy market, by Clinical Application
May 27, 2024 03:10 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application...
Circulating Tumor Cell (CTC) Market Forecast to Reach $26.1 Billion by 2032: Key Global and Regional Insights by Technology, Application, Product, Specimen, and End User
May 08, 2024 05:48 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032" report has been added to ...
United States Liquid Biopsy Market Analysis Report 2024: A $3.68 Billion Industry by 2032 from $1.06 Billion in 2023 - Emphasis on Companion Diagnostics, Increasing acceptance of Non-invasive Techniques
April 19, 2024 04:27 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market Report by Cancer types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032"...
Global Circulating Tumor Cells Market Projected to Reach USD 27.55 Billion by 2030, Driving Advancements in Cancer Management
March 29, 2024 05:37 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone...
Global Liquid Biopsy Market Report 2018-2035: Increasing Partnerships and Collaborations to Foster Progress and Innovation
March 04, 2024 07:59 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample,...
Liquid Biopsy Market Analysis Reveals Revolutionary Diagnostic Advances and Growth Potential by 2027: Comprehensive Insights on Cancer Screening, Therapy Selection, and Minimal Residual Disease Detection
February 22, 2024 12:03 ET
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
Global Liquid Biopsy Market Analysis Report 2024-2030, Featuring Oncimmune, Guardant Health, Myriad Genetics, Biocept, Lucence Health, Freenome Holdings, Illumina & Epigenomics
January 24, 2024 05:39 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market Size, Share & Trends Analysis Report by Biomarker (Exosomes, CTC), Application (Cancer, Reproductive Health),...
Global Liquid Carton Market Set to Soar, Valued at $15.64 Billion by 2023, Driven by Rising Demand for Sustainable Packaging
October 26, 2023 09:38 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market (by Product & Services, Circulating Biomarker, End-User, Application & Region): Insights and Forecast with...